MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1093/cid/ciaf655

Медицинская библиотека · Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2026

Reproducible Identification of Staphylococcus aureus Bacteremia Clinical Subphenotypes.

Swets Maaike C, Bakk Zsuzsa, Westgeest Annette C, Ruffin Felicia, Korn Rachel, Jabbour Jean-Francois, La Priscilla, Tysall Luke, Dewar Simon, Sutherland Rebecca K, de Boer Mark G J, Groeneveld Geert H, Dockrell David H, van der Vaart Thomas W, Fowler Vance G, Russell Clark D, IDISA study team

СтатьяНаблюдательное исследованиеПоддержка NIH: внешняя программаПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

BACKGROUND

Clinical heterogeneity in Staphylococcus aureus bacteremia (SAB) complicates clinical management and research. We have previously identified 5 clinically distinct subphenotypes of SAB associated with differences in outcomes and response to adjunctive rifampicin. Here, we aimed to identify these subphenotypes in geographically diverse observational cohorts, including a higher prevalence of methicillin-resistant S. aureus (MRSA) bacteremia and the USA300 clone.

METHODS

We studied 3 cohorts of adults with SAB from observational studies: a UK retrospective study (Edinburgh cohort 2; n = 463); a Dutch prospective study (IDISA [Improved Diagnostic Strategies in Staphylococcus aureus bacteremia study]; n = 490); and a prospective US study (SABG-PCS [Staphylococcus aureus Bacteremia Group Prospective Cohort Study]; n = 755). Subphenotypes were identified from routinely available clinical data using latent class analysis.

RESULTS

Patients from the SABG-PCS cohort had greater multimorbidity and more MRSA bacteremia (40.2% [303 of 755]), including infection with the USA300 clone (14.7% [111 of 755]). Five distinct subphenotypes were identified in each cohort: (1) older age and cardiometabolic multimorbidity; (2) nosocomial acquisition and intravenous catheter portal of entry; (3) community acquisition and metastatic infection; (4) chronic kidney disease; and (5) younger age, injection drug use, and metastatic infection. Bacterial genotypes varied substantially between the Edinburgh 2 and SABG-PCS cohorts but did not differ between subphenotypes within each cohort. 90-day mortality was highest in subphenotype A, and persistent bacteremia in subphenotypes C and E.

CONCLUSIONS

We have reproducibly identified 5 clinical subphenotypes of SAB in observational cohorts including diverse bacterial genetic lineages and a cohort with a high prevalence of MRSA and USA300 bacteremia. These robustly reproducible clinical subphenotypes provide a framework to rationalize the heterogeneity intrinsic to SAB.

Для цитирования: Swets Maaike C, Bakk Zsuzsa, Westgeest Annette C, Ruffin Felicia, Korn Rachel, Jabbour Jean-Francois, La Priscilla, Tysall Luke, Dewar Simon, Sutherland Rebecca K, de Boer Mark G J, Groeneveld Geert H, Dockrell David H, van der Vaart Thomas W, Fowler Vance G, Russell Clark D, IDISA study team. Reproducible Identification of Staphylococcus aureus Bacteremia Clinical Subphenotypes.. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2026. DOI: 10.1093/cid/ciaf655.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.